Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijoa.2024.104228 | DOI Listing |
Int J Obstet Anesth
November 2024
Rotunda Hospital, Dublin, Ireland.
We conducted a prospective observational service evaluation across the United Kingdom on the use of total intravenous anaesthesia (TIVA) for obstetric surgery between November 2022 and June 2023. The primary aim was to describe the incidence of TIVA for obstetric surgery within participating units, with secondary aims to describe maternal and neonatal postoperative recovery indicators. Of 184 maternity units in the United Kingdom, 30 (16%) contributed data to the service evaluation.
View Article and Find Full Text PDFProc (Bayl Univ Med Cent)
February 2024
Department of Anesthesiology, University of Virginia, Charlottesville, Virginia, USA.
Background: Our hypothesis was that total intravenous anesthesia (TIVA) is associated with an increase in hypothermia.
Methods: Inclusion criteria were patients from the National Anesthesia Clinical Outcomes Registry undergoing a general anesthetic during 2019. Data collected included patient age, sex, American Society of Anesthesiologists physical status classification system score (ASAPS), duration of anesthetic, use of TIVA, type of procedure, and hypothermia.
Cureus
February 2024
Internal Medicine, Brookdale University Hospital Medical Center, New York City, USA.
In this systematic review, the perioperative outcomes of total intravenous anesthesia (TIVA) and volatile anesthesia were compared in obese adults (BMI ≥ 30 kg/m²) undergoing elective surgery. The review analyzed data from 12 randomized-controlled trials involving 935 patients, sourced from PubMed/MEDLINE (Medical Literature Analysis and Retrieval System Online), Cochrane, Scopus, and Web of Science databases. The focus was on intraoperative vital signs, emergence time, postoperative nausea and vomiting (PONV), duration of post-anesthesia care unit (PACU) stay, and ICU admission rates.
View Article and Find Full Text PDFFront Surg
April 2023
Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Objective: To explore the influences of total intravenous anesthesia (TIVA) and inhaled-intravenous anesthesia on the prognosis of patients with lung, breast, or esophageal cancer.
Methods: In this retrospective cohort study, patients with lung, breast, or esophageal cancer who underwent surgical treatments at Beijing Shijitan Hospital between January 2010 and December 2019 were included. The patients were categorized into the TIVA group and inhaled-intravenous anesthesia group, according to the anesthesia methods used for the patients for surgery of the primary cancer.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!